Skip to main content
Log in

Fungi in Cystic Fibrosis: Recent Findings and Unresolved Questions

  • Pediatric Fungal Infections (T Lehrnbecher, Section Editor)
  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

Patients with cystic fibrosis (CF) suffer from chronic airway infection and inflammation. Traditionally, bacteria have been regarded the main CF pathogens while fungi have emerged and more recently warranted greater attention. Fungi are increasingly found to colonize CF airways; however, their precise clinical impact continues to spark controversy. While the clinical relevance of allergic bronchopulmonary aspergillosis (ABPA) in CF has been established, the roles of non-ABPA Aspergillus fumigatus, Candida albicans, and other more rare emerging fungi remain poorly understood. Here, we summarize and discuss recent findings in this field and refer toward unresolved questions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1996;154(5):1229–56.

    Article  CAS  PubMed  Google Scholar 

  2. de Vrankrijker AM, Wolfs TF, van der Ent CK. Challenging and emerging pathogens in cystic fibrosis. Paediatr Respir Rev. 2010;11(4):246–54.

    Article  PubMed  Google Scholar 

  3. Chotirmall SH, McElvaney NG. Fungi in the cystic fibrosis lung: bystanders or pathogens? Int J Biochem Cell Biol. 2014;52:161–73.

    Article  CAS  PubMed  Google Scholar 

  4. Chotirmall SH, Greene CM, McElvaney NG. Candida species in cystic fibrosis: a road less travelled. Med Mycol. 2010;48 Suppl 1:S114–24.

    Article  PubMed  Google Scholar 

  5. Chotirmall SH, Al-Alawi M, Mirkovic B, Lavelle G, Logan PM, Greene CM, et al. Aspergillus-associated airway disease, inflammation, and the innate immune response. BioMed Res Int. 2013;2013:723129.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis–state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis. 2003;37 Suppl 3:S225–64.

    Article  PubMed  Google Scholar 

  7. Moss RB. Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis. Curr Opin Pulm Med. 2010;16(6):598–603.

    Article  PubMed  Google Scholar 

  8. Baxter CG, Rautemaa R, Jones AM, Webb AK, Bull M, Mahenthiralingam E, et al. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum. Thorax. 2013;68(7):652–7. The first clinical study showing that anti-Pseudomonas antibiotics reduce Aspergillus fumigatus in CF patients.

  9. Kurnatowski P, Kurnatowska AJ. Some aspects of host-fungus interactions. Wiad Parazytol. 2001;47(4):859–66.

    CAS  PubMed  Google Scholar 

  10. Muhlschlegal F, Fonzi W, Hoyer L, Payne T, Poulet FM, Clevenger J, et al. Molecular mechanisms of virulence in fungus-host interactions for Aspergillus fumigatus and Candida albicans. Med Mycol. 1998;36 Suppl 1:238–48.

    CAS  PubMed  Google Scholar 

  11. Liu JC, Modha DE, Gaillard EA. What is the clinical significance of filamentous fungi positive sputum cultures in patients with cystic fibrosis? J Cyst Fibros. 2013;12(3):187–93.

    Article  PubMed  Google Scholar 

  12. Muller FM, Seidler M. Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis. Expert Rev Anti-Infect Ther. 2010;8(8):957–64.

    Article  PubMed  Google Scholar 

  13. Baxter CG, Dunn G, Jones AM, Webb K, Gore R, Richardson MD, et al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol. 2013;132(3):560–6.e10. The first systematic study stratifying Aspergillus fumigatus-associated disease phenotypes in CF patients based on immune parameters.

  14. Luong ML, Chaparro C, Stephenson A, Rotstein C, Singer LG, Waters V, et al. Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis. Transplantation. 2014;97(3):351–7. The first study correlating the Aspergillus fumigatus colonization status with the risk of developing invasive aspergillosis after lung transplantation in CF patients.

  15. Armstead J, Morris J, Denning DW. Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis. Plos One. 2014;9(6):e98502.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Baxter CG, Moore CB, Jones AM, Webb AK, Denning DW. IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis. Chest. 2013;143(5):1351–7.

    Article  CAS  PubMed  Google Scholar 

  17. Wahab AA, Taj-Aldeen SJ, Kolecka A, ElGindi M, Finkel JS, Boekhout T. High prevalence of Candida dubliniensis in lower respiratory tract secretions from cystic fibrosis patients may be related to increased adherence properties. Int J Infect Dis. 2014;24:14–9.

    Article  PubMed  Google Scholar 

  18. Parize P, Billaud S, Bienvenu AL, Bourdy S, le Pogam MA, Reix P, et al. Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. J Cyst Fibros. 2014.

  19. Kondori N, Lindblad A, Welinder-Olsson C, Wenneras C, Gilljam M. Development of IgG antibodies to Exophiala dermatitidis is associated with inflammatory responses in patients with cystic fibrosis. J Cyst Fibros. 2014;13(4):391–9.

    Article  CAS  PubMed  Google Scholar 

  20. Hernandez-Hernandez F, Frealle E, Caneiro P, Salleron J, Durand-Joly I, Accoceberry I, et al. Prospective multicenter study of Pneumocystis jirovecii colonization among cystic fibrosis patients in France. J Clin Microbiol. 2012;50(12):4107–10.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Bernhardt A, Sedlacek L, Wagner S, Schwarz C, Wurstl B, Tintelnot K. Multilocus sequence typing of Scedosporium apiospermum and Pseudallescheria boydii isolates from cystic fibrosis patients. J Cyst Fibros. 2013;12(6):592–8.

    Article  CAS  PubMed  Google Scholar 

  22. Masoud-Landgraf L, Badura A, Eber E, Feierl G, Marth E, Buzina W. Modified culture method detects a high diversity of fungal species in cystic fibrosis patients. Med Mycol. 2014;52(2):179–86.

    PubMed  Google Scholar 

  23. Shoseyov D, Brownlee KG, Conway SP, Kerem E. Aspergillus bronchitis in cystic fibrosis. Chest. 2006;130(1):222–6.

    Article  PubMed  Google Scholar 

  24. Aaron SD, Vandemheen KL, Freitag A, Pedder L, Cameron W, Lavoie A, et al. Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study. Plos One. 2012;7(4):e36077. The first randomized placebo-controlled trial of antifungals in CF patients colonized with Aspergillus fumigatus.

  25. Jones AM, Horsley A, Denning DW. What is the importance of classifying Aspergillus disease in cystic fibrosis patients? Expert Rev Respir Med. 2014;8(4):389–92.

    Article  CAS  PubMed  Google Scholar 

  26. Chotirmall SH, O’Donoghue E, Bennett K, Gunaratnam C, O’Neill SJ, McElvaney NG. Sputum Candida albicans presages FEV(1) decline and hospital-treated exacerbations in cystic fibrosis. Chest. 2010;138(5):1186–95.

    Article  PubMed  Google Scholar 

  27. Pihet M, Carrere J, Cimon B, Chabasse D, Delhaes L, Symoens F, et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis—a review. Med Mycol. 2009;47(4):387–97.

    Article  PubMed  Google Scholar 

  28. Khare R, Gupta S, Arif S, Jentoft ME, Deziel PJ, Roden AC, et al. Misidentification of Neosartorya pseudofischeri as Aspergillus fumigatus in a lung transplant patient. J Clin Microbiol. 2014;52(7):2722–5.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Vanhee LM, Nelis HJ, Coenye T. What can be learned from genotyping of fungi? Med Mycol. 2010;48 Suppl 1:S60–9.

    Article  PubMed  Google Scholar 

  30. Chotirmall SH, Mirkovic B, Lavelle GM, McElvaney NG. Immunoevasive aspergillus virulence factors. Mycopathologia. 2014.

Download references

Compliance With Ethics Guidelines

Conflict of Interest

O Eickmeier, A Hector, A Singh, SH Chotirmal, and D Hartl all declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dominik Hartl.

Additional information

This article is part of the Topical Collection on Pediatric Fungal Infections

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eickmeier, O., Hector, A., Singh, A. et al. Fungi in Cystic Fibrosis: Recent Findings and Unresolved Questions. Curr Fungal Infect Rep 9, 1–5 (2015). https://doi.org/10.1007/s12281-014-0211-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-014-0211-0

Keywords

Navigation